Drug Discovery of COPD

Chronic obstructive pulmonary disease is an increasing worldwide medical issue and cause of death. COPD predominantly influencing small airway routes and lung parenchyma that prompts dynamic aviation route deterrent. COPD is a standout amongst the most widely recognized infections on the globe, and there is a global increase in prevalence, however there are no drugs available at present that halt the relentless progression of this disease. In any case, a superior comprehension of the cell and molecular mechanisms that are associated with the underlying inflammatory and destructive processes has uncovered a few new focuses for which drugs are presently being developed, and the prospects for finding new medications are good.

    Related Conference of Drug Discovery of COPD

    March 18-19, 2020

    11th Annual Congress on Pulmonology & Respiratory Medicine

    Amsterdam, Netherlands
    June 29-30, 2020

    International Conference on Probiotics and Prebiotics

    Frankfurt, Germany
    October 19-20, 2020

    International Congress and Expo on Pulmonology

    Manila, Philippines
    October 29-30, 2020

    International Conference on Lung Diseases

    Cape Town, South Africa
    November 18-19, 2020

    International Conference on Asthma and Allergy

    Lisbon, Portugal
    December 07-08, 2020

    8th Annual Congress on Pulmonary and Critical Care

    Tokyo, Japan

    Drug Discovery of COPD Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in